Investors

Financials & Filings

Document Details

Form
Filing Date
Jun 24, 2025
Document Date
Jun 23, 2025
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.
Filer
Cline Darren S

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals